These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 17203011

  • 1. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.
    McCann UD, Peterson SC, Ricaurte GA.
    Neuropsychopharmacology; 2007 Aug; 32(8):1695-706. PubMed ID: 17203011
    [Abstract] [Full Text] [Related]

  • 2. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

  • 3. Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.
    McCann UD, Wilson MJ, Sgambati FP, Ricaurte GA.
    J Neurosci; 2009 Nov 04; 29(44):14050-6. PubMed ID: 19890014
    [Abstract] [Full Text] [Related]

  • 4. Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    McCann UD, Edwards RR, Smith MT, Kelley K, Wilson M, Sgambati F, Ricaurte G.
    Psychopharmacology (Berl); 2011 Oct 04; 217(4):475-84. PubMed ID: 21603895
    [Abstract] [Full Text] [Related]

  • 5. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
    Quednow BB, Kühn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M.
    Psychopharmacology (Berl); 2007 Jan 04; 189(4):517-30. PubMed ID: 16425060
    [Abstract] [Full Text] [Related]

  • 6. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan 04; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar 04; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 8. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
    Curran HV, Verheyden SL.
    Psychopharmacology (Berl); 2003 Aug 04; 169(1):91-103. PubMed ID: 12759801
    [Abstract] [Full Text] [Related]

  • 9. Patterns of memory dysfunction in current and 2-year abstinent MDMA users.
    Ward J, Hall K, Haslam C.
    J Clin Exp Neuropsychol; 2006 Apr 04; 28(3):306-24. PubMed ID: 16618622
    [Abstract] [Full Text] [Related]

  • 10. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.
    McCann UD, Mertl M, Eligulashvili V, Ricaurte GA.
    Psychopharmacology (Berl); 1999 Apr 04; 143(4):417-25. PubMed ID: 10367560
    [Abstract] [Full Text] [Related]

  • 11. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
    Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H.
    J Neurol Neurosurg Psychiatry; 2000 Jun 04; 68(6):719-25. PubMed ID: 10811694
    [Abstract] [Full Text] [Related]

  • 12. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
    McCann UD, Eligulashvili V, Ricaurte GA.
    Neuropsychobiology; 2000 Jun 04; 42(1):11-6. PubMed ID: 10867551
    [Abstract] [Full Text] [Related]

  • 13. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K.
    J Psychopharmacol; 1998 Jun 04; 12(1):79-83. PubMed ID: 9584971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A.
    Rev Neurol; 1998 Jun 04; 41(2):108-14. PubMed ID: 16028190
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.
    McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA.
    Psychopharmacology (Berl); 1999 Nov 04; 147(1):56-65. PubMed ID: 10591869
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug 04; 27(5):819-27. PubMed ID: 12921915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.